Bramshill Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bramshill Investments's BMY Position: Q2 2026 in Review
Bramshill Investments opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 13,561 shares worth $781K. The stake represents 0.06% of the portfolio and ranks #93 among its holdings. This is a return to the name: Bramshill Investments previously reported a position in BMY as recently as Q3 2025.
Bramshill Investments first reported a position in BMY in Q3 2025 and has held it in 2 quarters since. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Bramshill Investments held 13,561 shares of Bristol-Myers Squibb worth $781K as of Q2 2026.
- Bristol-Myers Squibb was a new Bramshill Investments position in Q2 2026.
- Bristol-Myers Squibb made up 0.06% of Bramshill Investments's portfolio in Q2 2026, its #93 holding.
- Bramshill Investments first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 2 quarters since.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Bramshill Investments's 13F filing for Q2 2026, filed 14 Aug 2026.